ACQUIRED · 2021
Who Acquired RQM+?
Linden Capital Partners · $385.0M· 19.3× EBITDA
The acquisition
RQM+ was acquired by Linden Capital Partners in 2021 for $385.0M. The deal was priced at 19.3× EBITDA.
RQM+ at time of acquisition
EBITDA
$20.0M
Deal value
$385.0M
EV / EBITDA
19.3×
Other acquisitions by Linden Capital Partners
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- Collagen Matrix, Inc. · 2019 · $425.0M · 14.2× EBITDA
Similar medical devices acquisitions
- Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
- Acera Surgical · acquired by Solventum in 2025 · $725.0M
- Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
- B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
- BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M
Run a valuation for a similar medical devices business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical devices calculator →More on medical devices valuations
- Medical Devices valuation calculator· head-term variant
- Medical Devices median multiples· real-deal benchmarks
- How to value a medical devices· long-form guide
Sourced from Press reporting. Full deal page.
Citation: ExitValue.ai. (2021). RQM+ acquired by Linden Capital Partners. https://exitvalue.ai/acquired/rqm